All results
22 results for stronger study
-
Study for Evaluating the EVAHEART?2 LVAS: the COMPETENCE Trial (COMPETENCE)
This is a prospective, multi-center, unblinded, randomized, controlled, and non-inferiority study comparing the EVA2 LVAS to the most recent magnetically…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome (AEGIS-II)
This is a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of CSL112 on reducing…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Enroll-HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Enroll-HD is a longitudinal, observational, multinational study that integrates two former Huntington's disease (HD) registries-REGISTRY in Europe, and COHORT…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Phase 3 Trial of PROTHROMPLEX TOTAL for Reversal of Direct Oral Factor Xa Inhibitor-induced Anticoag
The aim of this study is to find out the effects of TAK-330 compared with four-factor prothrombin complex concentrate (4F-PCC) as part of standard treatment…
- Ages
- 18 Years - N/A
- Sexes
- All
-
REC
A phase 2 study, aiming to evaluate the efficacy, safety and pharmacokinetics of REC 0/0559 in treatment of Neurotrophic Keratitis in Adult Patient in Europe…
- Ages
- 18 Years - N/A
- Sexes
- All
-
SERENDIPITY-1
The purpose of this study is to investigate the safety and efficacy of the current hard gelatin capsule formulation of NRD135S.E1 80 mg once daily in the…
- Ages
- 18 Years - N/A
- Sexes
- All
-
RECOVER VITAL
This study is a platform protocol designed to be flexible so that it is suitable for a wide range of settings within health care systems and in community…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Efficacy and Safety of the HAV W/AVF in Female Patients With End-Stage Renal Disease
The goal of this clinical trial is to compare the number of catheter-free days (CFD) and the rate and severity of any dialysis access-related infections…
- Ages
- 18 Years - N/A
- Sexes
- Female
-
Octapharma LEX-210
This is a multicentre, prospective, randomised, double-blinded, group-sequential, parallel-group, adaptive design, phase 3 study to demonstrate the haemostatic…
- Ages
- 18 Years - N/A
- Sexes
- All
-
ToPP-UP
This proposed research is relevant to human health because preemptive clinical pharmacogenetic testing may improve the personalization of drug therapy which…
- Ages
- 18 Years - N/A
- Sexes
- All